US Broker Ratings

Atrium Therapeutics (RNA) Stock Report: Navigating the Biotech Sector with a Market Cap of $229.93 Million

Atrium Therapeutics, Inc. (RNA) is carving its niche in the dynamic biotechnology sector, with a particular focus on RNA therapeutics aimed at treating cardiomyopathies. Headquartered in San Diego, California, this..

Bio-Techne Corp (TECH) Stock Analysis: Exploring a 39.64% Potential Upside in Healthcare Innovation

Bio-Techne Corp (NASDAQ: TECH) is a prominent player in the healthcare sector, specifically within the biotechnology industry. With a market capitalization of $8.43 billion and a robust portfolio of life..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Capitalizing on a 49.91% Potential Upside with Groundbreaking Biopharma Innovations

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a commercial-stage biopharmaceutical firm, is capturing significant attention in the biotechnology sector due to its pioneering focus on rare neuroendocrine diseases. Headquartered in Boston, Massachusetts,..

Glaukos Corporation (GKOS) Stock Analysis: Understanding the 25% Potential Upside

Glaukos Corporation (NYSE: GKOS), a leader in the medical devices sector with a focus on ophthalmic pharmaceuticals and medical technology, has been making waves in the healthcare industry. With a..

Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring an 83.84% Potential Upside in Biotech Innovation

Vaxcyte, Inc. (NASDAQ: PCVX) is capturing investor attention with its remarkable potential upside of 83.84%, as evidenced by the average analyst target price of $109, compared to its current trading..

Haleon plc (HLN) Stock Analysis: Navigating a 16.03% Potential Upside in the Healthcare Sector

Haleon plc (HLN), a pivotal player in the healthcare sector, presents a compelling investment opportunity with a notable potential upside of 16.03%, according to the latest analyst ratings. Operating from..

Quest Diagnostics (DGX) Stock Analysis: Unlocking a 9.68% Potential Upside in Healthcare Diagnostics

Quest Diagnostics Incorporated (NYSE: DGX), a prominent player in the healthcare sector, continues to capture investor attention with its robust market presence and promising growth prospects. With a market cap..

Lantheus Holdings, Inc. (LNTH)

⚠️ No article content returned.

..

Alcon Inc. (ALC) Investor Outlook: Exploring a 15.94% Potential Upside in the Eye Care Giant

For investors seeking opportunities in the healthcare sector, Alcon Inc. (NYSE: ALC) presents a compelling case. With a significant market cap of $40.65 billion, this Swiss-based leader in the medical..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Potential Upside Shines Amid Analyst Confidence

Prestige Consumer Healthcare Inc. (NYSE: PBH) stands out as a noteworthy player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market cap of..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Evaluating a 20% Upside Potential Amidst Stable Revenue Growth

Bio-Rad Laboratories, Inc. (NYSE: BIO), a prominent player in the healthcare sector, particularly in the medical devices industry, is drawing attention from investors due to its promising growth potential and..

Option Care Health, Inc. (OPCH) Stock Analysis: Strong Buy Ratings Point to 34% Upside Potential

Option Care Health, Inc. (NASDAQ: OPCH), a leader in the healthcare sector specializing in home and alternate site infusion services, is capturing investor attention with its robust growth prospects and..

BrightSpring Health Services, I (BTSG): Investor Outlook Reveals Potential 22.92% Upside

BrightSpring Health Services, Inc. (BTSG) stands as a notable player in the healthcare sector, specifically within the health information services industry. Headquartered in Louisville, Kentucky, this company has carved out..

Chemed Corp (CHE) Stock Analysis: Is the 8.61% Potential Upside Worth Your Investment?

Chemed Corp (NYSE: CHE), a key player in the healthcare sector, stands out with its diverse operations spanning hospice and palliative care services through its VITAS segment, and plumbing and..

TG Therapeutics, Inc. (TGTX): Investor Outlook with a Promising 51.79% Potential Upside

TG Therapeutics, Inc. (NASDAQ: TGTX) is capturing investor attention with its significant potential upside of 51.79% and a robust market cap of $4.67 billion. Based in Morrisville, North Carolina, this..

BeOne Medicines Ltd. (ONC) Stock Analysis: Strong Buy Ratings and 36% Upside Potential

BeOne Medicines Ltd. (ONC), a prominent player in the biotechnology sector, has captured the attention of investors with its promising growth metrics and robust pipeline of oncology treatments. Founded in..

Elanco Animal Health (ELAN) Stock Analysis: Navigating a 23% Potential Upside in the Animal Health Market

Elanco Animal Health Incorporated (NYSE: ELAN), a key player in the healthcare sector, has garnered significant attention in the investment community due to its comprehensive portfolio in animal health products...

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Unveiling a 25% Potential Upside for Investors

Halozyme Therapeutics, Inc. (NASDAQ: HALO) stands as a formidable player in the biotechnology sector, with a market capitalization of $7.95 billion. Based in San Diego, California, the company is renowned..

Guardant Health, Inc. (GH) Stock Analysis: Unlocking a 45.36% Potential Upside in the Diagnostics Sector

Guardant Health, Inc. (NASDAQ: GH) presents a compelling opportunity for investors looking to tap into the burgeoning field of precision oncology. As a key player in the diagnostics and research..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Unpacking Growth Potential and Analyst Consensus

Medpace Holdings, Inc. (NASDAQ: MEDP) has established itself as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $13.36 billion,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds